MedTrace Logo

Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c

NCT03092882 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 607

Last updated 2019-06-25

No results posted yet for this study

Summary

The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Self-Management Program on A1c levels for individuals with uncontrolled Type 2 diabetes.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Diabetes Self-Management Program

The Diabetes Self-Management Program is a platform that includes a smart meter, access to coaching 24/7, and a mobile app and website that help members manage their diabetes. The program offers diabetes education and coaching delivered entirely through the smart meter and mobile app or website.

Sponsors & Collaborators

  • Humana Co.Ltd.

    collaborator INDUSTRY

  • Evidation Health

    lead INDUSTRY

Principal Investigators

  • Jessie Juusola, PhD · Evidation Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-03
Primary Completion
2018-02-07
Completion
2018-02-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03092882 on ClinicalTrials.gov